Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study

Fig. 3

Tornado diagrams for the ICERs, including all HPV-related disease. ICER = incremental cost-effectiveness ratio; HPV = human papillomavirus; ¥ = Japanese Yen. Girls-only vaccination with 4vHPV included routine vaccination of 12–16-year old girls with 4vHPV from 2021 onwards; Girls-only routine and catch-up vaccination with 9vHPV consisted of routine vaccination of 12–16-year old girls from 2021 onwards and temporary catch-up vaccination of 17–26 years old girls and women with 9vHPV until 2025. All vaccination strategies were combined with cervical cancer screening

Back to article page